Catherine Barrow

1.1k total citations
9 papers, 356 citations indexed

About

Catherine Barrow is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Catherine Barrow has authored 9 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Catherine Barrow's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (4 papers). Catherine Barrow is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (4 papers). Catherine Barrow collaborates with scholars based in Australia, New Zealand and United States. Catherine Barrow's co-authors include Ian D. Davis, Judy Browning, Jonathan Cebon, Duncan MacGregor, Sue Sturrock, Achim A. Jungbluth, Scot Ebbinghaus, Kenneth Emancipator, Matteo S. Carlino and Christian U. Blank and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Catherine Barrow

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Barrow Australia 5 263 231 142 30 20 9 356
Yangyi Bao China 9 220 0.8× 229 1.0× 90 0.6× 42 1.4× 19 0.9× 17 346
Efrat Merhavi-Shoham Israel 8 197 0.7× 217 0.9× 157 1.1× 40 1.3× 37 1.9× 8 321
Heather Brouwer United Kingdom 6 350 1.3× 250 1.1× 83 0.6× 26 0.9× 8 0.4× 7 408
Reynold Yee United States 10 196 0.7× 226 1.0× 167 1.2× 48 1.6× 10 0.5× 11 314
Serina Tokita Japan 10 182 0.7× 164 0.7× 143 1.0× 34 1.1× 9 0.5× 28 291
Denise K. Oseguera United States 7 534 2.0× 431 1.9× 189 1.3× 35 1.2× 48 2.4× 7 593
Jan C. Schmollinger Germany 7 195 0.7× 194 0.8× 102 0.7× 24 0.8× 42 2.1× 8 304
Alexandra A. Schonnesen United States 5 168 0.6× 145 0.6× 131 0.9× 28 0.9× 15 0.8× 7 271
Erev E. Tubb United States 4 442 1.7× 278 1.2× 72 0.5× 28 0.9× 18 0.9× 5 506
Paul Shafer United States 5 153 0.6× 200 0.9× 85 0.6× 19 0.6× 40 2.0× 8 290

Countries citing papers authored by Catherine Barrow

Since Specialization
Citations

This map shows the geographic impact of Catherine Barrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Barrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Barrow more than expected).

Fields of papers citing papers by Catherine Barrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Barrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Barrow. The network helps show where Catherine Barrow may publish in the future.

Co-authorship network of co-authors of Catherine Barrow

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Barrow. A scholar is included among the top collaborators of Catherine Barrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Barrow. Catherine Barrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McLachlan, Jennifer, et al.. (2024). Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand. JCO Oncology Practice. 21(3). 358–364. 1 indexed citations
2.
Eggermont, Alexander M.M., Andrey Meshcheryakov, Victoria Atkinson, et al.. (2021). Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase 3 trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma.. Journal of Clinical Oncology. 39(15_suppl). 9500–9500. 3 indexed citations
3.
Carlino, Matteo S., Georgina V. Long, Dirk Schadendorf, et al.. (2018). Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial. European Journal of Cancer. 101. 236–243. 79 indexed citations
4.
Gasser, Olivier, Katrina Sharples, Catherine Barrow, et al.. (2017). A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. Cancer Immunology Immunotherapy. 67(2). 285–298. 44 indexed citations
5.
Desai, Jayesh, Hui Gan, Catherine Barrow, et al.. (2016). Abstract CT005: Phase I study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors. Cancer Research. 76(14_Supplement). CT005–CT005. 2 indexed citations
6.
Carlino, Matteo S., Antoni Ribas, René González, et al.. (2016). Abstract CT004: KEYNOTE-006: PD-L1 expression and efficacy in patients (Pts) treated with pembrolizumab (pembro) vs ipilimumab (IPI) for advanced melanoma. Cancer Research. 76(14_Supplement). CT004–CT004. 5 indexed citations
7.
Nicholaou, Theo, Weisan Chen, Ian D. Davis, et al.. (2011). Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™. Cancer Immunology Immunotherapy. 60(11). 1625–1637. 35 indexed citations
8.
Barrow, Catherine, Judy Browning, Duncan MacGregor, et al.. (2006). Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage. Clinical Cancer Research. 12(3). 764–771. 186 indexed citations
9.
Cebon, Jonathan, Ian D. Davis, Catherine Barrow, et al.. (2004). Quantitation of immune responses against the cancer testis antigen NY-ESO-1 following vaccination with protein with and without ISCOMATRIX adjuvant. Journal of Clinical Oncology. 22(14_suppl). 2518–2518. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangyi Bao Breakdown of academic impact, for papers by Efrat Merhavi-Shoham Breakdown of academic impact, for papers by Heather Brouwer Breakdown of academic impact, for papers by Reynold Yee Breakdown of academic impact, for papers by Serina Tokita Breakdown of academic impact, for papers by Denise K. Oseguera Breakdown of academic impact, for papers by Jan C. Schmollinger Breakdown of academic impact, for papers by Alexandra A. Schonnesen Breakdown of academic impact, for papers by Erev E. Tubb Breakdown of academic impact, for papers by Paul Shafer
Rankless by CCL
2026